Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in primary antiphospholipid syndrome
RBR-35mp4qCompleted
- Sponsor
- Hemocentro Unicamp
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of hydroxychloroquine in antiphospholipid syndrome (APS), sponsored by Hemocentro Unicamp. Started Nov 2014; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on RBR-35mp4q.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-35mp4q.